# Acurx Pharmaceuticals, Inc.: Form S-1, filed May 4, 2026

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2026-05-04
- Accepted by EDGAR: May 4, 2026, 16:09 ET
- Period: not reported
- Accession: 0001104659-26-054887
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465926054887/tm2611792d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465926054887/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465926054887/tm2611792d1_s1.htm

Filed May 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-054887. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.